首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >A Cost‐Benefit Analysis of Government Compensation of Kidney Donors
【2h】

A Cost‐Benefit Analysis of Government Compensation of Kidney Donors

机译:肾脏捐献者政府补偿的成本效益分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

From 5000 to 10 000 kidney patients die prematurely in the United States each year, and about 100 000 more suffer the debilitating effects of dialysis, because of a shortage of transplant kidneys. To reduce this shortage, many advocate having the government compensate kidney donors. This paper presents a comprehensive cost‐benefit analysis of such a change. It considers not only the substantial savings to society because kidney recipients would no longer need expensive dialysis treatments—$1.45 million per kidney recipient—but also estimates the monetary value of the longer and healthier lives that kidney recipients enjoy—about $1.3 million per recipient. These numbers dwarf the proposed $45 000‐per‐kidney compensation that might be needed to end the kidney shortage and eliminate the kidney transplant waiting list. From the viewpoint of society, the net benefit from saving thousands of lives each year and reducing the suffering of 100 000 more receiving dialysis would be about $46 billion per year, with the benefits exceeding the costs by a factor of 3. In addition, it would save taxpayers about $12 billion each year.
机译:在美国,每年有5000至10,000名肾脏病患者过早死亡,由于移植肾的短缺,约有100,000名患有透析的衰弱作用。为了减少这种短缺,许多人主张让政府赔偿肾脏捐赠者。本文对这种变化进行了全面的成本效益分析。它不仅考虑到社会可观的节省,因为肾脏接受者不再需要昂贵的透析治疗(每位肾脏接受者为145万美元),而且还估计了肾脏接受者享有的更长寿和更健康的生命的货币价值-每位接受者约为130万美元。这些数字使提议的每肾脏$ 45 000-000的补偿金相形见that,这可能是结束肾脏短缺和消除肾脏移植等待名单的必要条件。从社会的角度来看,每年挽救数千条生命并减少100,000多例接受透析的痛苦的净收益每年约为460亿美元,收益超过成本的三倍。每年将为纳税人节省约120亿美元。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号